Concepedia

HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody

Wei Wang, Yasuhiko Nishioka, Shuji Ozaki, Ali Jalili, Shinji Abe, Soji Kakiuchi, Masatoshi Kishuku, Kazuo Minakuchi, Toshio Matsumoto, Saburo Sone

Cancer Immunology Immunotherapy · 2008 · 61 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways

Akio Matsuda, Yutaka Suzuki, Goichi Honda et al. · Oncogene · 2003 · 390 citations

, , +13

Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

Ali O. Güre, Ramon Chua, Barbara Williamson et al. · Clinical Cancer Research · 2005 · 361 citations

Expression of mage genes by non‐small‐cell lung carcinomas

P. Weynants, Bernard Lethé, F. Brasseur et al. · International Journal of Cancer · 1994 · 231 citations

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12.

Yasuhiko Nishioka, Motohiro Hirao, Paul D. Robbins et al. · PubMed · 1999 · 230 citations

, , +16